The Cancer News | Author Submission Guidelines

Welcome to The Cancer News, an independent news platform delivering trusted oncology and hematology insights to clinicians, researchers, policymakers, patients, and families worldwide. Our author submission guidelines provide a clear framework for contributing high-quality articles that bridge scientific rigor with accessible, patient-centered communication. Whether you're reporting on a practice-changing clinical trial, analyzing emerging therapies, examining health policy shifts, offering expert commentary, or exploring global oncology, you'll find a dedicated submission template below tailored to your article type. Each template outlines the recommended structure, word count, tone, and section-by-section guidance to help your work reach a broad professional and lay audience effectively.

At a glance, The Cancer News accepts five article formats:

  • Clinical Trial Coverage (1,500–2,500 words) — In-depth reporting on trial design, findings, and clinical implications
  • Field Updates (1,500–2,000 words) — Overviews of emerging therapies and evolving treatment landscapes
  • Health Policy (1,500–2,000 words) — Analysis of regulations, access, and equity in cancer care
  • Expert Commentary (1,000–1,500 words) — Focused interpretation of trials, therapies, or trends from leading voices
  • Oncology Without Borders (1,500–2,000 words) — Global perspectives on disparities, innovations, and best practices

All submissions should balance scientific accuracy with plain-language explanations, include verified references, and feature author headshots and bios where applicable. Please review the relevant template carefully before submitting your draft.

Please send submissions to: [email protected]

Tips for authors contributing to The Cancer News:

  • Keep total article length 1,500–2,000 words.
  • Use plain-language explanations for patient-focused sections.
  • Use bullet points for takeaways and key highlights.
  • Ensure accurate references for all trial results, guidelines, and statements.
  • Maintain clarity and balance between scientific detail and readability.

Author Submission Templates:

The Cancer News | Clinical Trial Coverage Article - Author Submission Template

  • Target word count: 1,500–2,500 words
  • Audience: Oncologists, hematologists, and patients/families
  • Tone: Professional, clear, and accessible; include patient-friendly explanations where indicated

  1. Introduction / Context (150–250 words) Brief description of the cancer type and current treatment landscape; why this trial matters

  2. Trial Overview (150–250 words) Trial name, phase, design, patient population, endpoints, sponsor, presentation/publication venue

  3. Key Clinical Findings (400–600 words) Efficacy: response rates, OS, PFS; Safety: adverse events, toxicity; optional patient-friendly summary

  4. Comparison with Prior Trials / Standard of Care (200–300 words) Contextualize results with historical controls or first-line regimens; include expert commentary

  5. Clinical Implications / Practice Takeaways (150–250 words) Treatment sequencing, patient selection, emerging strategies; bullet points recommended

  6. Patient Perspective / Plain-Language Summary (150–200 words) Explain trial meaning for patients/families, side effects, benefits, quality-of-life considerations

  7. Expert Commentary (100–150 words) Author or other expert insights; optional video/audio snippet

  8. Key Takeaways Box (optional, 50–100 words) 3–5 bullets summarizing the most important points

  9. FAQs (3–5 questions, 100–150 words) Example: What is the trial drug? Who is eligible? Side effects? How does it compare to standard treatments? Are trials available?

  10. References / Links Include journal articles, conference abstracts, and internal Binaytara articles

  11. Images / Figures Upload files of any images or figures. Please use high-resolution images. Please include a headshot image of each author.

The Cancer News | Field Update Article - Author Submission Template

  • Target word count: 1,500–2,000 words
  • Audience: Oncologists, hematologists, and patients/families
  • Tone: Professional, clear, accessible; include patient-friendly explanations where indicated
  • Fill each section with relevant content; bullet points are allowed for clarity

  1. Introduction / Context (200–250 words) Overview of the cancer type or therapeutic area and why this update is relevant

  2. Emerging Therapies & Novel Agents (400–500 words) Highlight new drugs, combinations, or mechanisms. Include patient-friendly explanations of how therapies work and potential benefits.

  3. Clinical Practice Updates (300–400 words) Describe how emerging therapies affect treatment algorithms, guidelines, sequencing, patient selection, and monitoring. Optional plain-language summary for patient relevance.

  4. Key Trial Highlights (300–400 words) Summarize recent studies driving change, including trial names, endpoints, outcomes, and context with prior standard-of-care studies.

  5. Expert Insights / Commentary (150–200 words) Author’s analysis of clinical implications, controversies, and future directions. Optional quote, video, or visual snippet.

  6. Patient Perspective / Plain-Language Summary (150–200 words) Explain key updates in easy-to-understand terms. Discuss potential benefits, side effects, and questions patients may ask their care team.

  7. Key Takeaways / Summary Box (50–100 words) 3–5 concise bullets summarizing the most important practical insights and trends.

  8. FAQs (3–5 questions, ~100–150 words total) Examples: What are the newest therapies for [cancer type]? How do updates change standard treatment? Who may benefit? What trials are available? How are side effects managed?

  9. References / Links Include recent journal publications, conference abstracts, guideline updates, and internal Binaytara articles.

The Cancer News | Health Policy Article - Author Submission Template

  • Target word count: 1,500–2,000 words
  • Audience: Oncologists, hematologists, policymakers, and patients/families
  • Tone: Professional, clear, accessible; include patient-friendly explanations where indicated

  1. Introduction / Policy Context (200–250 words) Overview of the health policy topic or issue Relevance to cancer care, access, or health system improvement

  2. Policy Developments & Updates (400–500 words) Recent policies, regulations, or guidelines affecting oncology care Include national, regional, or global perspectives Explain implications for healthcare providers and patients

  3. Impact on Access & Care Delivery (300–400 words) How the policy changes affect access to cancer treatment, diagnostics, or supportive care Include patient-centered perspectives and equity considerations

  4. Evidence & Data Supporting Policy Changes (300–400 words) Include relevant studies, health economics, or outcomes data Contextualize findings for clinicians and policymakers

  5. Expert Commentary / Insights (150–200 words) Analysis from policy experts, clinicians, or advocacy leaders Optional quote or multimedia snippet

  6. Patient / Community Perspective (150–200 words) Explain how policy affects patients and families Highlight potential benefits, challenges, and questions patients may have

  7. Key Takeaways / Summary Box (50–100 words) 3–5 bullets summarizing the most important policy implications for oncology care

  8. FAQs (3–5 questions, ~100–150 words) Example: What does this policy change mean for patient access? How will providers implement it? Are there funding or coverage impacts?

  9. References / Links Include policy documents, regulatory updates, research studies, and Binaytara internal publications

The Cancer News | Expert Commentary Article - Author Submission Template

  • Target word count: 1,000–1,500 words
  • Audience: Oncologists, hematologists, and patients/families
  • Tone: Professional, clear, and accessible; include patient-friendly explanations where indicated

  1. Introduction / Context (150–200 words) Why this topic, trial, or therapy matters now

  2. Expert Analysis / Interpretation (400–600 words) Discuss trial implications, mechanisms, clinical significance, pros/cons, and uncertainties

  3. Clinical Implications / Practice Takeaways (200–300 words) Recommendations for sequencing, patient selection, follow-up; bullet points optional

  4. Patient Perspective / Plain-Language Summary (100–150 words) Explain in plain language how this expert opinion may affect patient care

  5. Key Takeaways / Highlights Box (3–5 bullets, 50–100 words)

  6. References / Links Journal articles, conference abstracts, and internal Binaytara articles

The Cancer News | Oncology Without Borders Article - Author Submission Template

  • Target word count: 1,500–2,000 words
  • Audience: Oncologists, hematologists, policymakers, global health professionals, and patients/families
  • Tone: Professional, clear, accessible; highlight global relevance
  • Topics: Health equity, global oncology, cancer healthcare disparities

  1. Introduction / Global Context (200–250 words) Overview of global oncology issues (access, disparities, innovations) Why this topic matters across countries or regions

  2. Regional / Country Highlights (400–500 words) Updates from specific regions or countries regarding cancer care, guidelines, or programs Include differences in access, infrastructure, and outcomes

  3. Innovations & Global Best Practices (300–400 words) Describe new approaches, collaborations, or strategies improving global cancer care Include patient-centered examples and scalable solutions

  4. Data, Evidence & Outcomes (300–400 words) Present global data or studies supporting interventions or programs Highlight disparities, gaps, and measurable outcomes

  5. Expert Commentary / Insights (150–200 words) Input from global oncology leaders, clinicians, or researchers Optional quote or multimedia snippet

  6. Patient / Population Perspective (150–200 words) How global initiatives affect patients and communities Consider quality-of-life, equity, and access issues

  7. Key Takeaways / Summary Box (50–100 words) 3–5 concise bullets summarizing practical insights for global oncology stakeholders

  8. FAQs (3–5 questions, ~100–150 words) Example: How can global disparities in cancer care be addressed? What are emerging treatment models? Which regions show most progress?

  9. References / Links Include peer-reviewed studies, global reports, guidelines, and internal Binaytara resources

To submit an article to The Cancer News for consideration, please email us at:

[email protected]